A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control

Revision as of 16:22, 10 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control; V Bhaskar, ID Goldfine, DH Bedinger, A Lauae; 2012; doi_citing_unknown == Retraction == Positive and Negative Roles of p85a and p85ß Regulatory Subunits of Phosphoinositide 3-Kinase in Insulin Signaling ; Kohjiro Ueki David A Fruman Claudine M Yballe Mathias Fasshauer Johannes Klein Tomoichiro Asano; 09/22/2003 ; https://doi.org/10...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Target ArticleEdit

A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control; V Bhaskar, ID Goldfine, DH Bedinger, A Lauae; 2012; doi_citing_unknown

RetractionEdit

Positive and Negative Roles of p85a and p85ß Regulatory Subunits of Phosphoinositide 3-Kinase in Insulin Signaling  ; Kohjiro Ueki David A Fruman Claudine M Yballe Mathias Fasshauer Johannes Klein Tomoichiro Asano; 09/22/2003

https://doi.org/10.1074/jbc.M305602200

Citation pieceEdit

Note: Open to append information.